Follow
Julie Bertrand
Julie Bertrand
Verified email at inserm.fr - Homepage
Title
Cited by
Cited by
Year
Timing of antiviral treatment initiation is critical to reduce SARS‐CoV‐2 viral load
A Gonçalves, J Bertrand, R Ke, E Comets, X De Lamballerie, D Malvy, ...
CPT: pharmacometrics & systems pharmacology 9 (9), 509-514, 2020
2332020
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness
A Marc, M Kerioui, F Blanquart, J Bertrand, O Mitja, M Corbacho-Monné, ...
Elife 10, e69302, 2021
1312021
Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose–response models
EL Plan, A Maloney, F Mentré, MO Karlsson, J Bertrand
The AAPS journal 14, 420-432, 2012
772012
Guide pour la mise en œuvre de la gouvernance en appui au développement durable des territoires
H Rey-Valette, M Pinto, P Maurel, E Chia, PY Guihéneuf, L Michel, ...
auto-saisine, 2011
722011
Dependence of Efavirenz- and Rifampicin-Isoniazid–Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms …
J Bertrand, C Verstuyft, M Chou, L Borand, P Chea, KH Nay, FX Blanc, ...
The Journal of infectious diseases 209 (3), 399-408, 2014
662014
Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients
M Chou, J Bertrand, O Segeral, C Verstuyft, L Borand, E Comets, ...
Antimicrobial agents and chemotherapy 54 (10), 4432-4439, 2010
612010
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART
J Bertrand, JM Treluyer, X Panhard, A Tran, S Auleley, E Rey, ...
European journal of clinical pharmacology 65, 667-678, 2009
572009
Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters
J Bertrand, E Comets, F Mentre
Journal of biopharmaceutical statistics 18 (6), 1084-1102, 2008
562008
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer’s disease
S Reeves, E McLachlan, J Bertrand, F D’Antonio, S Brownings, A Nair, ...
Brain 140 (4), 1117-1127, 2017
542017
Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm
J Bertrand, E Comets, CM Laffont, M Chenel, F Mentré
Journal of pharmacokinetics and pharmacodynamics 36, 317-339, 2009
472009
Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians
J Bertrand, M Chou, DM Richardson, C Verstuyft, PD Leger, F Mentré, ...
Pharmacogenetics and genomics 22 (12), 868-876, 2012
442012
A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status
S Reeves, J Bertrand, SJ Obee, S Hunter, R Howard, RJ Flanagan
British Journal of Clinical Pharmacology 90 (1), 135-145, 2024
392024
Development of a complex parent-metabolite joint population pharmacokinetic model
J Bertrand, CM Laffont, F Mentré, M Chenel, E Comets
The AAPS journal 13, 390-404, 2011
362011
Mathematical expressions of the pharmacokinetic and pharmacodynamic models implemented in the PFIM software
A Dubois, J Bertrand, F Mentré
UMR738, INSERM, Paris Diderot University, 2011
352011
Some alternatives to asymptotic tests for the analysis of pharmacogenetic data using nonlinear mixed effects models
J Bertrand, E Comets, M Chenel, F Mentré
Biometrics 68 (1), 146-155, 2012
272012
Mathematical expressions of the pharmacokinetic and pharmacodynamic models implemented in the Monolix software
J Bertrand, F Mentré
Paris Diderot University, 1-68, 2008
272008
Multiple single nucleotide polymorphism analysis using penalized regression in nonlinear mixed-effect pharmacokinetic models
J Bertrand, DJ Balding
Pharmacogenetics and genomics 23 (3), 167-174, 2013
262013
Bayesian inference using Hamiltonian Monte‐Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy
M Kerioui, F Mercier, J Bertrand, C Tardivon, R Bruno, J Guedj, S Desmée
Statistics in Medicine 39 (30), 4853-4868, 2020
232020
Can a flavored spray (pill glide) help children swallow their medicines? A pilot study
M Jagani, H Legay, SR Ranmal, J Bertrand, K Ooi, C Tuleu
Pediatrics 138 (6), 2016
232016
Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late‐onset schizophrenia‐like psychosis (VLOSLP)
S Reeves, K Eggleston, E Cort, E McLachlan, S Brownings, A Nair, ...
International journal of geriatric psychiatry 33 (2), 396-404, 2018
222018
The system can't perform the operation now. Try again later.
Articles 1–20